Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/20765
Full metadata record
DC FieldValueLanguage
dc.contributor.authorContopoulos-Ioannidis, D. G.en
dc.contributor.authorNtzani, E.en
dc.contributor.authorIoannidis, J. P.en
dc.date.accessioned2015-11-24T19:09:55Z-
dc.date.available2015-11-24T19:09:55Z-
dc.identifier.issn0002-9343-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20765-
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subject*Biomedical Researchen
dc.subjectHumansen
dc.subjectIndustryen
dc.subjectMedical Laboratory Scienceen
dc.subject*Randomized Controlled Trials as Topicen
dc.subjectResearch Support as Topicen
dc.subjectTime Factorsen
dc.titleTranslation of highly promising basic science research into clinical applicationsen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/12731504-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2003-
heal.abstractPURPOSE: To evaluate the predictors of and time taken for the translation of highly promising basic research into clinical experimentation and use. METHODS: We identified 101 articles, published between 1979 and 1983 in six major basic science journals, which clearly stated that the technology studied had novel therapeutic or preventive promises. Each case was evaluated for whether the promising finding resulted in relevant randomized controlled trials and clinical use. Main outcomes included the time to published trials, time to published trials with favorable results ("positive" trials), and licensed clinical use. RESULTS: By October 2002, 27 of the promising technologies had resulted in at least one published randomized trial, 19 of which had led to the publication of at least one positive randomized trial. Five basic science findings are currently licensed for clinical use, but only has been used extensively for the licensed indications. Promising technologies that did not lead to a published human study within 10 to 12 years were unlikely to be tested in humans subsequently. Some form of industry involvement in the basic science publication was the strongest predictor of clinical experimentation, accelerating the process by about eightfold (95% confidence interval: 3 to 19) when an author had industry affiliations. CONCLUSION: Even the most promising findings of basic research take a long time to translate into clinical experimentation, and adoption in clinical practice is rare.en
heal.journalNameAmerican Journal of Medicineen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons